Search

As an autoimmune disease, Type 1 diabetes raises important questions about immune cell activity that have broad implications for immunotherapy.

… Tuesday, November 30, 2021 To an immunologist, autoimmune diseases like Type 1 diabetes are the polar opposite of cancer. In the former, the immune system goes into overdrive and attacks the body’s own organs in a relentless manner, eventually causing disease; with cancer, the immune system shuts down

A recent study led by investigators at MSK and published in Nature Medicine, included a comprehensive analysis of non relapse mortality after CAR T cell therapy in patients with lymphoma and multiple myeloma across multiple clinical trials and real-world studies. In this Q&A we discuss the study's key findings and a new tool for assessing infection risk prior to CAR T cell therapy.

… Monday, July 8, 2024 A Q&A with MSK Visiting Investigator and Research Fellow Dr. Kai Rejeski CAR T cell therapy against CD19 and B cell maturation antigen (BCMA) is a potent immunotherapy for treating advanced B cell malignancies. It comes with a unique toxicity profile that includes cytokine release

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, June 22, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Selwyn M. Vickers, MD, FACS, President and CEO Selwyn Vickers Named Among 50 Most Influential Clinical Executives by Modern Healthcare Selwyn M. Vickers, MD, FACS , President and

Seventeen scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 17, 2023, as part of Memorial Sloan Kettering’s 44th annual academic convocation.

… Monday, May 15, 2023 This year 17 scientists who did their training at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) are poised to receive their doctorates, the highest number ever to graduate from GSK in a single year. Their years of dedication and training will be recognized

… Wednesday, February 11, 2026 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Maximilian Merz Awarded $2.3 Million From the Hector Foundation  Maximilian Merz Maximilian Merz, MD, mmyeloma specialist, has been  awarded $2.3 million by the Hector Foundation

Dendritic cells, the guards of the immune system, have a previously unrecognized division of labor.

… Thursday, October 24, 2019 Summary Scientists at the Sloan Kettering Institute have made a fundamental discovery about how dendritic cells in the immune system are organized into distinct types. The results could inform immunotherapy for cancer and other diseases. Biologists sometimes liken the immune

Memorial Sloan Kettering researchers will lead and present notable research at the American Association for Cancer Research (AACR) Virtual Annual Meeting II.

… Friday, June 19, 2020 Thousands of oncology experts from around the world will tune in virtually June 22-24 for the American Association for Cancer Research (AACR) Virtual Annual Meeting II . Memorial Sloan Kettering (MSK) researchers will lead and present some of the most notable research at the meeting

Find tools for discussing a cancer diagnosis with your children.

… Tuesday, November 26, 2019 Summary There is no easy way to tell your child that you have cancer. However, there are ways to include them in the conversation and make sure they feel supported. Being diagnosed with cancer raises all sorts of questions. And if you’re a parent, you’re likely facing one question

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing.

… Tuesday, August 1, 2023 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by  U.S. News & World Report  in its annual Best Hospitals

Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to co-opt natural wound-healing pathways. In a literal sense, metastasis is wound healing gone wrong. These findings provide a novel framework for thinking about metastasis and how to treat it.

… Monday, January 13, 2020 Bottom Line:  Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to co-opt natural wound-healing pathways. In a literal sense, metastasis is wound healing gone wrong. These findings